You can buy or sell Exicure and other stocks, options, ETFs, and crypto commission-free!
Exicure, Inc. Common Stock, also called Exicure, is a clinical-stage biotechnology company, which engages in the discovery, research, and development of treatments based on spherical nucleic acid technology (SNA). Read More It focuses on neurology, immuno-oncology, inflammatory diseases, and other genetic disorders. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.
52 Week High
52 Week Low
— per share
Expected Nov 15, Pre-Market